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A ROLE FOR INTERLEUKINS IN THE RAPID PROGRESSION OF
OSTEOARTHRITIS IN ALKAPTONURIA
A. Taylor y, M. Bukhari z, J. Mistry y. y Lancaster Univ., Lancaster, United
Kingdom; zUniv. Hosp. of Morecambe Bay NHS Fndn. Trust, Lancaster,
United Kingdom
Purpose: Alkaptonuria (AKU) is a rare autosomal recessive disorder
of tyrosine metabolism which causes rapidly progressing, early
onset osteoarthritis (OA). The diseases results from absence of the
enzyme homogentisate 1,2 dioxygenase, this enzyme breaks down
homogentisic acid (HGA). Levels of HGA are elevated systemically
from birth and over time HGA undergoes polymerisation, a process
called ochronosis. Ochronosis occurs predominantly in weight
bearing cartilages in hips, knees and intervertebral discs where it
causes ochronotic osteoarthropathy. Research into AKU has dem-
onstrated that focal change within cartilage is required to allow
ochronosis to occur; quickly followed by progression to devastating
ochronotic osteoarthropathy. The exact change that occurs within
the cartilage matrix that initiates the pigmentation process is
unknown. One potential candidate is trauma or damage resulting in
local inﬂammation and subsequent pigmentation. Our aim is to
examine the effect of both pro- and anti-inﬂammatory interleukins;
IL-1B, IL-6 and IL-10 respectively, on pigmentation (ochronosis) and
cell viability in an in vitro model of ochronotic osteoarthropathy in
AKU
Methods: C20 chondrosarcoma cells were seeded into 24 well plates
and cultured for 21 days in medium under the following conditions:
control, HGA, IL-1B or IL-6 or IL-10, HGAþIL-1B. Reagents were added to
medium at 0.33M for HGA and 1ng/ml for IL-1, 6 and 10. Medium was
changed every 3rd day. Cultures (n ¼ 6) for histological examination
were ﬁxed and then stained with schmorl’s reagent and nuclear fast red
to highlight pigmentation and allow quantiﬁcation. The effect of
reagents on cell viability was assessed by trypan blue assay. Statistical
analysis consisted of analysis of variance and differences between
groups was determined by Newman-Keuls post-test, all performed
using Graphpad Prism software
Results: C20 cultures treated with HGA (solely or in combination
with IL’s) demonstrated highly signiﬁcant increases in the number of
pigment deposits compared to control and IL cultures (p<0.001).
When comparing HGA solely against HGA in combination with IL-1,
-6 or -10 there were no signiﬁcant differences between groups.
Analysis of cell viability with IL-1 demonstrated that all culture
conditions showed a highly signiﬁcant decrease in cell number
compared to control (p<0.001). There was no signiﬁcance between
control and IL-1 alone. C20 cells cultured in HGA alone showed a
highly signiﬁcant decrease in cell number compared to HGAþIL-1.
Analysis of cultures with Il-6 showed that HGA and HGA þ Il-6 both
showed a highly signiﬁcant decrease compared to control (p<0.001).
Cells cultured in IL-6 alone showed no difference compared to con-
trol. C20 cells cultured in HGAþIL-6 showed a highly signiﬁcant
decrease in cell number compared to IL-6 alone (p<0.001), but no
difference to HGA alone. C20 cells cultured with HGA and HGAþIL-10
both showed a highly signiﬁcant decrease in cell numbers compared
to control. Cultures of HGAþIL-10 showed a highly signiﬁcant
decrease in cell numbers compared to IL-10 alone (p<0.001), but no
difference when compared to HGA alone. There was no difference
between HGA and HGAþIL-10
Conclusions: We demonstrate that addition of interleukins alongside
HGA does not appear to have an effect on the number of pigment
deposits compared to HGA alone. This suggests that the presence of
interleukins alongside HGA does not produce more pigmentation.
However the interleukins do appear to have an effect on cell viability,
most interestingly the addition of IL-1 alongside HGA does not appear
to be as detrimental to cell number as HGA alone. This may be why the
arthropathy in AKU is much earlier onset and rapid in progression than
that in OA. Also of interest is that anti-inﬂammatory interleukins do
not appear to reduce the decrease in cell number when used in
combination with HGA. In summary these results are the ﬁrst to
examine the combination of HGA and interleukins in the arthropathy
of AKU and the results suggest that the presence of interleukins does
not cause more pigmentation but they do appear to have a detrimental
effect on the number of cells present and as such may be a factor in
altering the extracellular milieu and promoting the degeneration
process.92
THE IMPORTANCE OF MESENCHYMAL STEM CELL DONOR’S AGE FOR
CARTILAGE ENGINEERING
Y. Li y, N. Charif y, D. Mainard y,z, J-F. Stoltz y,z, N. de Isla y. yCNRS UMR
7365, Vandoeuvre, France; zNancy Hosp., Nancy, France
In 1994, Brittber et coll. showed that cultured autologous chondrocytes
could be used to repair deep cartilage defects of the knee joint. But,
several problems are observed due to the differentiation of chon-
drocytes in culture leading to ﬁbrocartilage formation. More recently,
the use of bone marrow mesenchymal stem cells (BM-MSC) in cartilage
engineering has been used. As hinted by the role of stem cell senescence
and dysfunction in natural aging, donor or patient age will be a critical
factor that must be accounted for in clinical and laboratory evaluations
of bone marrow mesenchymal stem cell based technology.We eval-
uated in vitro chondrogenic differentiation of bone marrow mesen-
chymal stem cells in function of donor age and passage in culture. The
objective of such a study design was to provide a controlled analysis of
two variables (age and passage) and possible interaction between these
crucial factors in developing adult stem cell based therapeutics and for
which no consensus exists regarding their role in MSC differentiation.
Materials and Methods: Mesenchymal stem cells were obtained from
bonemarrow from human donors of different ages (n¼ 18, 3 to 85 years
old, mean age 49  27). Cells were isolated by plastic adherence (5 104
mononuclear cells/cm2) and cultured in a-MEMwith 10% SVF. After two
weeks cells were detached from culture ﬂasks and replated at 1000
cells/cm2. Then cells were passaged every two weeks. At each passage,
cells were counted, clonogenicity was tested by a colony forming unit
test and phenotypewas veriﬁed by ﬂow cytometry for the expression of
several markers (CD90, CD73, CD105, CD44, CD45, CD34, HLA-DR).
Chondrogenic potential was assayed after passage 1 and 4/5 using
speciﬁc differentiation media containing TGF-b. 2.5 x 105 cells were
used to form each chondrogenic pellet. After 28 days, Gene expression
of chondrogenic markers was evaluated by qPCR and matrix synthesis
by histology and alcian blue staining. Quantiﬁcation of staining areawas
performed by using ImageJ.
Results: Our study has revealed differences between proliferation
capacities of BM-MSC in function of donor’s age. Cells from old donors
proliferate slowly than cells from young donors and become senescent
after 4 or 5 passages. Two groups of donors have been deﬁned according
to proliferation capacity (less than 40 years old and over 40 years old).
Phenotype, clonogenicity and chondrogenic differentiation was studied
in the two groups. While cells expressed mesenchymal markers (CD90,
CD44, CD73, CD105) and did not expressed HLA-DR, CD45 or CD34, no
differences were observed in the expression level of the markers
according to donor’s age.
Clonogenicity was inceased for cells coming from young donors, both at
number or size levels. At the same time, young donors cells were
characterized by high level expression of type 2 collagen, aggrecan and
sox-9 genes after chondrogenic differentiationwhile cells from the> 40
years group showed a poor chondrogenic differentiation. Similar results
were observed at the matrix synthesis levels after alcian blue staining.
Cells from late passages showed decresed differentiation compared
with cells from early passages. However, at early passages, cells from
young donors presented a great differentiation potential than cells from
aged donors.
Conclusions: This study shows that differences on proliferation and
chondrogenic differentiation exist between mesenchymal stem cells
isolated from bone marrow obtained in young and old donors. These
results could be considered in the choice of MSC for cartilage tissue
engineering. The proliferation capacity of cells and their clonogenicity
are good parameters to rapidly estimate cell quality.
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LONGITUDINAL CHANGE IN OBJECTIVELY MONITORED STEPS/DAY
OVER 2-YEARS IN MIDDLE- TO OLDER-AGE ADULTS WITH OR AT
RISK OF KNEE OA: THE MOST STUDY
D.K. White y, C. Tudor-Locke z, Y. Zhang y, D. Felson y, K. Gross y,
M. Nevitt x, C.E. Lewis k, J. Torner{, T. Neogi y. yBoston Univ., Boston, MA,
USA; z Pennington BioMed. Reserach Ctr., Baton Rouge, LA, USA; xUCSF, San
Francisco, CA, USA; kUniv. Alabama Brimingham, Birmingham, AL, USA;
{Univ. of Iowa, Iowa City, IA, USA
Purpose: Maintaining an active lifestyle throughout the lifespan con-
fers a broad spectrum of health beneﬁts, including protection against
